论文部分内容阅读
目的:探讨糖类抗原(CA12-5)、糖类抗原(CA19-9)、癌胚抗原(CEA)、甲胎蛋白(AFP)、糖类抗原(CA15-3)5种肿瘤标志物联合检测在妇科肿瘤中应用价值。方法:用罗氏E1010电化学发光免疫分析仪联合检测240例妇科疾病患者肿瘤标志物。结果:妇科恶性肿瘤患者共29例,肿瘤标志物阳性结果仅10例占34.5,存在阳性率较低的问题。结论:适当联合检测肿瘤标志物对提高所观察恶性肿瘤的阳性率有一定价值,各肿瘤标志物间有明显的互补性,但无明显组织特异性,对妇科肿瘤的诊断具有一定参考意义。
Objective: To explore the combined detection of 5 tumor markers including carbohydrate antigen (CA12-5), carbohydrate antigen (CA19-9), carcinoembryonic antigen (CEA), alpha fetoprotein (AFP) and carbohydrate antigen In gynecologic oncology value. Methods: Tumor markers of 240 patients with gynecological diseases were detected by Roche E1010 electrochemiluminescence immunoassay analyzer. Results: A total of 29 patients with gynecological malignancies, the positive results of tumor markers in only 10 cases accounted for 34.5, there is a lower positive rate. Conclusion: Appropriate combined detection of tumor markers has some value in improving the positive rate of observed malignant tumors. There are obvious complementarity among the tumor markers, but no obvious tissue specificity, which is of certain reference value for the diagnosis of gynecologic tumors.